Back to Search
TAT YAU, M.D., M.P.H.
M.D., M.P.H.
Infectious Disease Physician
NPI: 1710418967IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
328032(LA)
CMS Specialties
PrimaryINFECTIOUS DISEASE
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 2017
Research & Publications (20)
Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis.
PMID 19668331·PLoS One·2009
7-preclinical
Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong.
PMID 19342734·Hong Kong Med J·2009
4-observational
Trends and patterns of breast conservation treatment in Hong Kong: 1994-2007.
PMID 19101091·Int J Radiat Oncol Biol Phys·2009
8-other
Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
PMID 19090486·J Pathol·2009
4-observational
Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
PMID 18581185·Ann Surg Oncol·2008
8-other
HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.
PMID 18382020·Hong Kong Med J·2008
4-observational
Surveillance mammography after breast conservation therapy in Hong Kong: effectiveness and feasibility of risk-adapted approach.
PMID 17905584·Breast·2008
8-other
Evaluation of the prognostic value of 2005 St Gallen risk categories for operated breast cancers in Hong Kong.
PMID 17804235·Breast·2008
8-other
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
PMID 17571263·Cancer Chemother Pharmacol·2008
5-case
Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
PMID 17379441·Int J Radiat Oncol Biol Phys·2007
3-trial
Enhanced angiogenesis with multimodal cell-based gene therapy.
PMID 17307468·Ann Thorac Surg·2007
7-preclinical
Treatment of Stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation: impact of chemotherapy schemes.
PMID 17145529·Int J Radiat Oncol Biol Phys·2006
2-rct
Wide local excision and radiotherapy for the treatment of ductal carcinoma in situ of the breast: the Hong Kong experience.
PMID 16909967·Clin Oncol (R Coll Radiol)·2006
8-other
Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma.
PMID 16721741·Head Neck·2006
8-other
Maximizing ventricular function with multimodal cell-based gene therapy.
PMID 16159803·Circulation·2005
4-observational
Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy.
PMID 15919309·Ann Thorac Surg·2005
7-preclinical
HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
PMID 15580286·Oncogene·2005
8-other
Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
PMID 15390194·Head Neck·2004
8-other
Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells.
PMID 12537212·Ann Thorac Surg·2003
7-preclinical
Auto/cross-regulation of Hoxb3 expression in posterior hindbrain and spinal cord.
PMID 12482716·Dev Biol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2000 TULANE AVE
NEW ORLEANS, LA 70112 - Phone
- (504) 702-4344
Quick Facts
- NPI
- 1710418967
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile